Cite

HARVARD Citation

    Braman, V. et al. (n.d.). A Randomized Phase I Evaluation of CTP‐499, a Novel Deuterium‐Containing Drug Candidate for Diabetic Nephropathy1. Clinical pharmacology in drug development. 2 (1), pp. 53-66. [Online]. 
  
Back to record